CDER Meetings, Conferences & Workshops: February - March 2020

February FDA-AACR Workshop to Examine Under-representation of African Americans in Multiple Myeloma Clinical Trials; February 13; Washington DC; Live webcast available FDA and MHRA Good Clinical Practice Symposium: Data Integrity in Global Clinical Trials - Tackling Challenging Topics in 2020; February 13-14; Hammersmith, London; Live webcast available Electronic Submission of Adverse Event Reports to FDA Adverse Event Reporting System (FAERS) using International Council for Harmonisation (ICH) E2B(R3) Standards; February 19; Silver Spring MD; Live webcast available Meeting of the Oncologic Drugs Advisory Committee; February 26; Silver Spring MD; Live webcast available FDA/CDER-AACR-IASLC Workshop to Address the Criticality of Tobacco Use Assessment in Oncology Therapeutic Trials; February 28; Silver Spring MD; Live webcast available March Advancing Animal Models for Antibacterial Drug Development; March 5; Silver Spring MD; Live webcast available Public Workshop: FDA/FTC Workshop on a Competitive Marketplace for Biosimilars; March 9; Silver Spring MD; Live webcast available Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder; March 10; Silver Spring MD; Live webcast available Identification of Concepts and Terminology for Multi-Component Biomarkers Workshop; March 23; Silver Spring MD; Live webcast available  Public Meeting on Patient-Focused Drug Development for Vitiligo; March 30; Silver Spring MD; Live webcast available